Tactile Systems Technology Inc income statement
In fiscal 2025, Tactile Systems Technology Inc reported revenue of $330m, up 12.5% on the year before, operating income of $29.3m (a 8.9% margin) and net income of $19.1m, or $0.82 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 63 | 85 | 109 | 144 | 189 | 187 | 208 | 247 | 274 | 293 | 330 | 356 |
| Cost of revenue | 13 | 17 | 23 | 29 | 41 | 55 | 54 | 60 | 71 | 79 | 76 | 79 | 82 |
| Gross profit | 35 | 46 | 62 | 80 | 102 | 134 | 133 | 148 | 176 | 195 | 217 | 250 | 274 |
| Research and development | 3 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 7 | 8 | 9 | 8 | 10 |
| Selling and marketing | 18 | 24 | 34 | 44 | 60 | 79 | 80 | 87 | 106 | 107 | 112 | 121 | 132 |
| General and administrative | 10 | 14 | 19 | 27 | 34 | 39 | 51 | 57 | 61 | 62 | 71 | 89 | 96 |
| Operating income | 4 | 3 | 4 | 4 | 3 | 10 | −4 | −2 | −13 | 18 | 22 | 29 | 34 |
| Interest expense | — | — | — | — | — | — | — | — | 3 | 4 | 2 | 1 | 0 |
| Income before tax | 4 | 3 | 4 | 4 | 3 | 11 | −2 | −2 | −15 | 16 | 23 | 31 | 36 |
| Income tax | 2 | 2 | 1 | −2 | −3 | 0 | −2 | 10 | 2 | −13 | 7 | 12 | 12 |
| Net income | 2 | 1 | 3 | 6 | 7 | 11 | −1 | −12 | −18 | 29 | 17 | 19 | 24 |
| Diluted EPS | $0.02 | −$0.15 | $0.15 | $0.31 | $0.34 | $0.56 | −$0.03 | −$0.60 | −$0.89 | $1.23 | $0.70 | $0.82 | $1.03 |
| Diluted shares (average) | 4m | 3m | 11m | 19m | 19m | 20m | 19m | 20m | 20m | 23m | 24m | 23m | 23m |
| EBITDA | 5 | 4 | 5 | 6 | 7 | 14 | −1 | 2 | −6 | 25 | 29 | 36 | 41 |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 86 | 61 | 79 | 86 | 104 | 75 | 86 | 92 |
| Cost of revenue | 21 | 16 | 20 | 21 | 23 | 18 | 20 | 21 |
| Gross profit | 64 | 45 | 59 | 65 | 81 | 58 | 65 | 70 |
| Research and development | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Selling and marketing | 29 | 28 | 30 | 30 | 34 | 33 | 32 | 33 |
| General and administrative | 20 | 20 | 22 | 21 | 25 | 23 | 23 | 25 |
| Operating income | 13 | −5 | 4 | 11 | 19 | −2 | 7 | 10 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 13 | −4 | 5 | 11 | 19 | −1 | 7 | 10 |
| Income tax | 3 | −1 | 1 | 3 | 9 | 1 | −0 | 3 |
| Net income | 10 | −3 | 3 | 8 | 11 | −2 | 8 | 7 |
| Diluted EPS | $0.40 | −$0.13 | $0.14 | $0.36 | $0.46 | −$0.08 | $0.34 | $0.31 |
| EBITDA | 14 | −3 | 6 | 13 | 20 | 0 | 9 | 11 |
Compare with peers
- Inogen Inc income statement
- Inmode Ltd. income statement
- Staar Surgical Co income statement
- Procept Biorobotics Corp income statement
- Angiodynamics Inc income statement
Head to head: INGN vs TCMDINMD vs TCMDSTAA vs TCMD
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies